GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...
GSK PLC on Thursday said its monoclonal antibody Nucala, also known as mepolizumab, has been accepted for review in China. The London-based pharmaceutical company said the China Medical Products ...
GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...
The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most ...
A roundup of recent health news highlights policy changes affecting FDA language use, drug industry meetings with President ...
These latest developments come just a few weeks after DeepSeek's release of a lower-cost AI model rattled markets, as it ...
GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years, and may also call upon ...
(Alliance News) - European stocks opened mixed on Thursday, with the FTSE 100 underperforming, as Russia-Ukraine uncertainty, tariff worries and the possibility of higher for longer interest rates ...
GSK has claimed its second breakthrough designation from the FDA for antibody-drug conjugate GSK5764227, which it licensed from China's Hansoh Pharma in a $1.7 billion deal. The status has been ...
JETEMA announced on the 17th that its subsidiary JETEMA Shanghai has signed a distribution and promotion contract for the ...
The pharmaceutical industry’s biggest lobbying group is scheduled to meet with President Donald Trump on Thursday, according ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results